Array CGH was performed to identify the breakpoints in 3 cases with deletions of 16p11.2p12.2 and 1 case with a duplication/triplication of 16p11.2p12.2.
Deep WGS sequencing (160x) of 2 different sites of disease of a patient with a RET fusion positive cancer.
Amplicon sequencing of 19 other sites of the same patients for the RET fusion.
